Enveric Biosciences Unveils EVM401 Series of Compounds with New U.S. Patent
Go back to Enveric Biosciences Unveils EVM401 Series of Compounds with New U.S. Patent| (NASDAQ: ENVB) | Delayed: 1.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.44 | 52 Week High | $ | |||
| Open | $1.44 | 52 Week Low | $ | |||
| Day High | $1.44 | P/E | N/A | |||
| Day Low | $1.44 | EPS | $ | |||
| Volume | 274 | |||||
